| For: | Haack A, Aragão GG, Novaes MRCG. Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases. World J Gastroenterol 2013; 19(46): 8552-8561 [PMID: 24379572 DOI: 10.3748/wjg.v19.i46.8552] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i46/8552.htm |
| Number | Citing Articles |
| 1 |
Elana Shaw, William M. Wuest. Virulence attenuating combination therapy: a potential multi-target synergy approach to treatPseudomonas aeruginosainfections in cystic fibrosis patients. RSC Medicinal Chemistry 2020; 11(3) doi: 10.1039/C9MD00566H
|
| 2 |
Giovanni Bacci, Alice Rossi, Federica Armanini, Lisa Cangioli, Ida De Fino, Nicola Segata, Alessio Mengoni, Alessandra Bragonzi, Annamaria Bevivino. Lung and Gut Microbiota Changes Associated with Pseudomonas aeruginosa Infection in Mouse Models of Cystic Fibrosis. International Journal of Molecular Sciences 2021; 22(22) doi: 10.3390/ijms222212169
|
| 3 |
Petra Pallagi, Péter Hegyi, Zoltán Rakonczay. The Physiology and Pathophysiology of Pancreatic Ductal Secretion. Pancreas 2015; 44(8) doi: 10.1097/MPA.0000000000000421
|
| 4 |
Ayda Awaness, Rania Elkeeb, Sepehr Afshari, Eman Atef. The Pharmacokinetic Changes in Cystic Fibrosis Patients Population: Narrative Review. Medicines 2024; 12(1) doi: 10.3390/medicines12010001
|
| 5 |
Dacia Malambo-García, Claudio Gómez-Alegría, Javier Baena-Del Valle, Maria Ruiz-Díaz, Eder Cano-Pérez, Doris Gómez-Camargo. Clinical, paraclinical, and genetic profile of patients with cystic fibrosis from Colombian Caribbean. Heliyon 2023; 9(6) doi: 10.1016/j.heliyon.2023.e17005
|
| 6 |
Fotios Sampaziotis, Miguel Cardoso de Brito, Pedro Madrigal, Alessandro Bertero, Kourosh Saeb-Parsy, Filipa A C Soares, Elisabeth Schrumpf, Espen Melum, Tom H Karlsen, J Andrew Bradley, William T H Gelson, Susan Davies, Alastair Baker, Arthur Kaser, Graeme J Alexander, Nicholas R F Hannan, Ludovic Vallier. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nature Biotechnology 2015; 33(8) doi: 10.1038/nbt.3275
|
| 7 |
David F. Kisor. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process. 2020; doi: 10.21019/9781582123127.ch23
|
| 8 |
Ruihe Shi, Xiufang Wang, Xiaojing Lu, Zhijie Zhu, Qingrong Xu, Haoran Wang, Li Song, Changlian Zhu. A systematic review of the clinical and genetic characteristics of Chinese patients with cystic fibrosis. Pediatric Pulmonology 2020; 55(11) doi: 10.1002/ppul.24980
|
| 9 |
Yajuan Chu, Jinfeng Shuai, Kunling Huang, Jianhua Liu, Wenshan Lv, Baochi Li, Songwen Tan. Analysis of Clinical Manifestations, Imaging Features, and Gene Mutation Characteristics of 6 Children with Cystic Fibrosis in China. Evidence-Based Complementary and Alternative Medicine 2021; 2021 doi: 10.1155/2021/7254391
|
| 10 |
David F. Kisor. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process, 2nd Edition. 2022; doi: 10.21019/9781582123844.ch24
|
| 11 |
Alisha Lakhani, Ruchira Clementina, Zainab Siddiqua, Shailee Shroff, Sravani Bhavanam, Maitrey Hareshkumar Pandya, Bhoomi Bagadia, Usman Khan, Mishal Mohammed Koyappathodi Machingal, Ankush Kimmatkar, Prachi Chunawala, Harpratap Singh, Hasim Reza, Madhavi Katta. Exploring Therapeutic Strategies for Pediatric Cystic Fibrosis: An In-Depth Comparative Review. Cureus 2024; doi: 10.7759/cureus.71913
|
| 12 |
Luiz Vicente Ribeiro F. Silva Filho, Claudio Castaños, Héctor Hernán Ruíz. Cystic fibrosis in Latin America—Improving the awareness. Journal of Cystic Fibrosis 2016; 15(6) doi: 10.1016/j.jcf.2016.05.007
|
| 13 |
E. I. Kondratieva, T. Yu. Maksimycheva, A. Yu. Voronkova, V. D. Sherman. Experience of using specialized mixture of enteral nutrition in children with nutritive deficiency in cystic fibrosis. Medical alphabet 2019; 2(21) doi: 10.33667/2078-5631-2019-2-21(396)-47-52
|
| 14 |
Yuelin Shen, Jinrong Liu, Lili Zhong, Peter J. Mogayzel, Pamela L. Zeitlin, Patrick R. Sosnay, Shunying Zhao. Clinical Phenotypes and Genotypic Spectrum of Cystic Fibrosis in Chinese Children. The Journal of Pediatrics 2016; 171 doi: 10.1016/j.jpeds.2015.12.025
|
| 15 |
Shahenda Ramadan, Salma N. Tammam, Maryam A. Shetab Boushehri, Hans-Georg Breitinger, Ulrike Breitinger, Samar Mansour, Alf Lamprecht. Liposomal delivery of functional transmembrane ion channels into the cell membranes of target cells; a potential approach for the treatment of channelopathies. International Journal of Biological Macromolecules 2020; 153 doi: 10.1016/j.ijbiomac.2019.10.238
|
| 16 |
Dapeng Zhang, Sha Li, Ning Wang, Hor-Yue Tan, Zhimin Zhang, Yibin Feng. The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.00301
|
| 17 |
Caroline Lemoine, Joan Lokar, Susanna A. McColley, Estella M. Alonso, Riccardo Superina. Cystic fibrosis and portal hypertension: Distal splenorenal shunt can prevent the need for future liver transplant. Journal of Pediatric Surgery 2019; 54(5) doi: 10.1016/j.jpedsurg.2019.01.035
|
| 18 |
Adithi Raghunath, Thejaswini Krishna, Parmar Keshri Nandan, Jayanthi Sivaraman. A Paradigm Shift in Cystic Fibrosis: Insights into Molecular Diagnosis, Newborn Screening, and Nanotechnology-Based Drug Delivery for CF Treatment. Current Respiratory Medicine Reviews 2025; 21(5) doi: 10.2174/011573398X359962250527113134
|
| 19 |
Kaya Sophie Lange, Lisa Marie Wiesner, Kathleen Susat, Vera Köhler, Malte Lenger, Christian Alexander Michalek, Anna-Lena Baack, Philip Frederic Mundt, Kai Kanthak, Isabell Alexandra Guckes, Liliana Sanfilippo, Lucas Haverkamp, Utkarsh Anil Mahajan, Felicitas Helena Zimmer, Sinan Zimmermann, Marco Tobias Radukic, Levin Joe Klages, Jörn Kalinowski, Kristian Mark Müller. Towards effective cystic fibrosis gene therapy by optimizing prime editing and pulmonary-targeted LNPs. Frontiers in Systems Biology 2025; 5 doi: 10.3389/fsysb.2025.1603749
|
| 20 |
Milena Luana Coelho de ASSIS, Constantino Giovanni Braga CARTAXO, Maria José de Carvalho COSTA, Dayanna Joyce Marques QUEIROZ, Darlene Carmati PERSUHN, Maria da Conceição Rodrigues GONÇALVES. Association between hematological profile and serum 25-hydroxyvitamin D levels and FokI polymorphism in individuals with cystic fibrosis. Revista de Nutrição 2018; 31(2) doi: 10.1590/1678-98652018000200007
|
| 21 |
Li-Yen Lee, Geena Suet Yin Hew, Meenu Mehta, Shakti D. Shukla, Saurabh Satija, Navneet Khurana, Krishnan Anand, Harish Dureja, Sachin Kumar Singh, Vijay Mishra, Pankaj Kumar Singh, Monica Gulati, Parteek Prasher, Alaa A.A. Aljabali, Murtaza M. Tambuwala, Lakshmi Thangavelu, Jithendra Panneerselvam, Gaurav Gupta, Flavia C. Zacconi, Madhur Shastri, Niraj Kumar Jha, Dikaia Xenaki, Ronan MacLoughlin, Brian G. Oliver, Dinesh Kumar Chellappan, Kamal Dua. Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. Life Sciences 2021; 267 doi: 10.1016/j.lfs.2020.118973
|
| 22 |
Zinat Heidari, Maryam Daei, Motahareh Boozari, Tannaz Jamialahmadi, Amirhossein Sahebkar. Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence. Phytotherapy Research 2022; 36(4) doi: 10.1002/ptr.7350
|
| 23 |
Andrew Burke, Daniel Smith, Chris Coulter, Scott C. Bell, Rachel Thomson, Jason A. Roberts. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis. Clinical Pharmacokinetics 2021; 60(9) doi: 10.1007/s40262-021-01010-4
|
| 24 |
Giuseppe Giuffrida, Alfredo Campennì, Salvatore Cannavò, Rosaria M. Ruggeri. Commentary: L-T4 Therapy in Enteric Malabsorptive Disorders. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.696768
|